Chu Nimes - Hopital Caremeau

Nîmes 30900

1 studies enrolling now · 9 studies all time

What they study most

Acute Respiratory Infection, Colitis, Ulcerative, Crohn's Disease, Depressive Disorder, Major, Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Ulcerative Colitis and Crohn's Disease, Urothelial Cancer

Studies at this site

• Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) — Recruiting now
• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years — Completed
• A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy — Completed
• A Study of Acute Respiratory Infections in Global Outpatient Setting — Completed
• Entyvio (Vedolizumab) Long Term Safety Study — Completed
• A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) — Completed